Risk assessment for neurobehavioral toxicity: SGOMSEC joint report.
Behavioral end points for neurotoxicity risk assessment have been developed and examined over the past three decades. They are now ready to move from simple qualitative guidelines, such as exemplified by reference doses, to more quantitative models, such as benchmark doses, based on dose-response information. Risk assessors, confronted by a wider array of methodologies and data than in the past, should be offered guidance in interpretation because now they have to deal with unaccustomed questions and problems. These include reversibility, susceptible populations, multiple end points, and the details of dose-response and dose-effect distributions.
Hattis
D
D
Marsh Institute Center for Technology, Clark University, Worcester, Massachusetts, USA.
Glowa
J
J
Tilson
H
H
Ulbrich
B
B
D000818:Animals; D001519:Behavior / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004781:Environmental Exposure; D006801:Humans; D009498:Neurotoxins / Q000009:adverse effects / Q000633:toxicity*; D015203:Reproducibility of Results; D018570:Risk Assessment; D018675:Toxicity Tests / Q000379:methods
D009498:Neurotoxins